In medicine Bionics refers to the flow of concepts from
biology to
engineering and vice versa. Hence, there are two slightly different points of view regarding the meaning of the word. In medicine,
bionics means the replacement or enhancement of
organs or other body parts by mechanical versions. Bionic implants differ from mere
prostheses by mimicking the original function very closely, or even surpassing it. The German equivalent of bionics,
Bionik, always adheres to the broader meaning, in that it tries to develop engineering solutions from biological models. This approach is motivated by the fact that biological solutions will usually be optimized by
evolutionary forces. While the technologies that make bionic implants possible are developing gradually, a few successful bionic devices already exist, a well known one being the Australian-invented multi-channel
cochlear implant (bionic ear), a device for
deaf people. Since the bionic ear, many bionic devices have emerged and work is progressing on bionics solutions for other sensory disorders (e.g. vision and balance). Bionic research has recently provided treatments for medical problems such as neurological and psychiatric conditions, for example
Parkinson's disease and
epilepsy. In 1997,
Colombian researcher
Alvaro Rios Poveda developed an upper limb and hand
prosthesis with
sensory feedback. This technology allows amputee patients to handle prosthetic hand systems in a more natural way. By 2004 fully functional
artificial hearts were developed. Significant progress is expected with the advent of
nanotechnology. A well-known example of a proposed nanodevice is a
respirocyte, an artificial red cell designed (though not yet built) by
Robert Freitas. In 2007 the Scottish company
Touch Bionics launched the first commercially available bionic hand, named "i-Limb Hand". According to the firm, by May 2010 it has been fitted to more than 1,200 patients worldwide. During his eight years in the Department of Bioengineering at the
University of Pennsylvania,
Kwabena Boahen developed a
silicon retina that was able to process images in the same manner as a living retina. He confirmed the results by comparing the electrical signals from his silicon retina to the electrical signals produced by a
salamander eye while the two retinas were looking at the same image. On July 21, 2015, the
BBC's medical correspondent
Fergus Walsh reported, "surgeons in Manchester have performed the first bionic eye implant in a patient with the most common cause of sight loss in the developed world. Ray Flynn, 80, has dry age-related
macular degeneration which has led to the total loss of his central vision. He is using a retinal implant that converts video images from a miniature video camera worn on his glasses. He can now make out the direction of white lines on a computer screen using the retinal implant." The implant, known as the
Argus II and manufactured in the US by the company
Second Sight Medical Products, had been used previously in patients who were blind as the result of the rare inherited degenerative eye disease
retinitis pigmentosa. In 2016,
Tilly Lockey (born October 7, 2005) was fitted with a pair of bionic "Hero Arms" manufactured by
OpenBionics, a UK bionics enterprise. The Hero Arm is a lightweight myoelectric prosthesis for below-elbow amputee adults and children aged eight and above. Tilly Lockey, who at 15 months had both her arms amputated after being diagnosed with
meningococcal sepsis strain B, describes the Hero Arms as "really realistic, to the point where it was quite creepy how realistic they were." On February 17, 2020, Darren Fuller, a military veteran, became the first person to receive a bionic arm under a public healthcare system. Fuller lost the lower section of his right arm while serving term in
Afghanistan during an incident that involved mortar ammunition in 2008.
Other uses Business biomimetics is the latest development in the application of biomimetics. Specifically it applies principles and practice from biological systems to business strategy, process, organization design, and strategic thinking. It has been successfully used by a range of industries in
FMCG, defense, central government, packaging, and business services. Based on the work by Phil Richardson at the
University of Bath the approach was launched at the
House of Lords in May 2009. Generally, biometrics is used as a
creativity technique that studies
biological prototypes to get ideas for engineering solutions. In chemistry, a
biomimetic synthesis is a
chemical synthesis inspired by
biochemical processes. Another, more recent meaning of the term bionics refers to merging organism and machine. This approach results in a hybrid system combining biological and engineering parts, which can also be referred as a cybernetic organism (
cyborg). Practical realization of this was demonstrated in
Kevin Warwick's implant experiments bringing about
ultrasound input via his own nervous system. == See also ==